MUNARI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 2.276
EU - Europa 1.833
AS - Asia 1.357
SA - Sud America 183
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 46
OC - Oceania 6
Totale 5.790
Nazione #
US - Stati Uniti d'America 2.177
RU - Federazione Russa 741
SG - Singapore 494
CN - Cina 386
GB - Regno Unito 300
IT - Italia 255
HK - Hong Kong 134
BR - Brasile 133
SE - Svezia 127
VN - Vietnam 126
DE - Germania 96
IE - Irlanda 76
FR - Francia 70
FI - Finlandia 64
CA - Canada 48
KR - Corea 48
BD - Bangladesh 34
IN - India 33
UA - Ucraina 30
MX - Messico 20
ES - Italia 15
JP - Giappone 15
EC - Ecuador 13
TR - Turchia 12
ID - Indonesia 11
PH - Filippine 11
AR - Argentina 10
NL - Olanda 10
BE - Belgio 9
VE - Venezuela 9
CO - Colombia 8
LT - Lituania 8
PL - Polonia 8
ZA - Sudafrica 8
NG - Nigeria 7
AU - Australia 6
BJ - Benin 6
CR - Costa Rica 6
JM - Giamaica 6
UZ - Uzbekistan 6
HN - Honduras 5
MY - Malesia 5
TG - Togo 5
IL - Israele 4
IR - Iran 4
JO - Giordania 4
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
CW - ???statistics.table.value.countryCode.CW??? 3
IQ - Iraq 3
NI - Nicaragua 3
NO - Norvegia 3
PK - Pakistan 3
PR - Porto Rico 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
AT - Austria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GN - Guinea 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
MA - Marocco 2
NP - Nepal 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
GD - Grenada 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NE - Niger 1
OM - Oman 1
PY - Paraguay 1
Totale 5.702
Città #
Ashburn 313
Moscow 267
Southend 248
Singapore 241
San Jose 216
Chandler 210
Dallas 191
Hong Kong 133
Jacksonville 97
Woodbridge 95
Council Bluffs 86
Verona 77
Dublin 75
Beijing 69
Ann Arbor 59
Los Angeles 49
Ho Chi Minh City 47
The Dalles 45
New York 40
Houston 31
Santa Clara 31
Jinan 28
Lawrence 28
Princeton 28
Helsinki 26
Nanjing 22
Columbus 21
Milan 20
Munich 20
São Paulo 20
Hanoi 18
Redmond 17
Rome 17
Bologna 16
Seoul 16
Tokyo 15
Wilmington 15
Buffalo 14
Shenyang 14
Sindelfingen 14
Denver 12
Frankfurt am Main 12
Redondo Beach 12
Tianjin 12
Turku 12
Hebei 11
London 11
Naples 11
Boardman 9
Brooklyn 9
Mexico City 9
Montreal 9
Toronto 9
Brussels 8
Dong Ket 8
Jiaxing 8
Las Vegas 8
Ningbo 8
Norwalk 8
Stockholm 8
Zhengzhou 8
Abuja 7
Atlanta 7
Detroit 7
Phoenix 7
Chennai 6
Cleveland 6
Cotonou 6
Fuzhou 6
Hangzhou 6
Johannesburg 6
Kingston 6
Madrid 6
Manchester 6
Nanchang 6
Taiyuan 6
Tashkent 6
Warsaw 6
Wuhan 6
Boston 5
Changsha 5
Chicago 5
Kyiv 5
Lancaster 5
Lomé 5
Orem 5
Saint Louis 5
Seattle 5
Taizhou 5
Amman 4
Buttapietra 4
Cagliari 4
Da Nang 4
Dongguan 4
Greer 4
Guayaquil 4
Haikou 4
Hải Dương 4
Lanzhou 4
McKinney 4
Totale 3.397
Nome #
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 254
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 244
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 227
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 224
PD-L1 expression in lung non small cell carcinoma: evaluation of heterogeneity and definition of bioptic criteria for improving patients selection 205
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 204
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 193
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 191
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 190
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 187
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 185
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 184
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 183
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 182
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 181
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 172
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists 171
Artificial intelligence in head and neck cancer diagnosis 170
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 161
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 160
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 154
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome 145
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 145
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 143
Delphi expert consensus for whole slide imaging in thyroid cytopathology 138
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 138
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability 132
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays 130
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 119
PD-L1 expression heterogeneity in non-small cell lung cancer: defining criteria for harmonization between biopsies and whole sections 116
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 109
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 100
Natural Language Processing to extract SNOMED-CT codes from pathological reports 92
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 89
AIDA: AI-Driven Intelligent Diagnostics and Analytics 64
The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolution 26
HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8+ tumor-infiltrating lymphocytes 24
Giant atherosclerotic left main coronary artery aneurysm: from revascularization to heart transplantation 22
Correction: HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8+ tumor-infiltrating lymphocytes 21
Cardiac Denervation and Reinnervation After Heart Transplantation: Assessment and Clinical Impact 15
Totale 5.790
Categoria #
all - tutte 20.311
article - articoli 17.647
book - libri 0
conference - conferenze 2.145
curatela - curatele 0
other - altro 519
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022108 0 0 0 0 8 8 8 12 7 5 15 45
2022/2023520 30 53 44 93 41 135 16 26 60 6 16 0
2023/2024264 6 15 34 36 26 50 7 18 7 22 37 6
2024/2025781 30 41 40 131 54 55 33 21 108 44 75 149
2025/20262.492 155 126 161 431 614 157 202 142 206 165 74 59
2026/2027587 54 99 123 288 23 0 0 0 0 0 0 0
Totale 5.790